MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.740
+0.090 (2.47%)
At close: Oct 10, 2024, 4:00 PM
3.670
-0.070 (-1.87%)
After-hours: Oct 10, 2024, 4:13 PM EDT
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $234.58 million as of October 10, 2024. Its market cap has decreased by -20.62% in one year.
Market Cap
234.58M
Enterprise Value
128.27M
1-Year Change
-20.62%
Ranking
Category
Stock Price
$3.74
Market Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $234.58M, a decrease of -60.92%. That is a compound annual growth rate of -8.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2024 | 228.90M | -61.64% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sera Prognostics | 230.91M |
| SOPHiA GENETICS | 230.41M |
| Corbus Pharmaceuticals Holdings | 228.71M |
| Utah Medical Products | 226.36M |
| ModivCare | 225.85M |
| Omeros | 223.10M |
| Fulcrum Therapeutics | 222.77M |
| Codexis | 221.29M |